About the Authors

Carol Dobson-Stone

Affiliations Neuroscience Research Australia, Sydney, Australia, School of Medical Sciences, University of New South Wales, Sydney, Australia

Marianne Hallupp

Affiliation Neuroscience Research Australia, Sydney, Australia

Clement T. Loy

Affiliations Neuroscience Research Australia, Sydney, Australia, School of Medical Sciences, University of New South Wales, Sydney, Australia, Huntington Disease Service, Westmead Hospital, Sydney, Australia, Sydney School of Public Health, University of Sydney, Sydney, Australia

Elizabeth M. Thompson

Affiliations South Australia Clinical Genetics Service, Women's and Children's Hospital, Adelaide, Australia, Department of Paediatrics, University of Adelaide, Adelaide, Australia

Eric Haan

Affiliations South Australia Clinical Genetics Service, Women's and Children's Hospital, Adelaide, Australia, Department of Paediatrics, University of Adelaide, Adelaide, Australia

Carolyn M. Sue

Affiliation Department of Neurogenetics, Kolling Institute of Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, Australia

Peter K. Panegyres

Affiliation Neurodegenerative Disorders Research Pty Ltd, Subiaco, Australia

Cristina Razquin

Affiliation Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain

Manuel Seijo-Martínez

Affiliation Department of Neurology, Hospital do Salnés, Pontevedra, Spain

Ramon Rene

Affiliation Department of Neurology, Hospital de Bellvitge, Barcelona, Spain

Jordi Gascon

Affiliation Department of Neurology, Hospital de Bellvitge, Barcelona, Spain

Jaume Campdelacreu

Affiliation Department of Neurology, Hospital de Bellvitge, Barcelona, Spain

Birgit Schmoll

Affiliation Institute of Human Genetics, University Hospital Ulm, Ulm, Germany

Alexander E. Volk

Affiliation Institute of Human Genetics, University Hospital Ulm, Ulm, Germany

William S. Brooks

Affiliations Neuroscience Research Australia, Sydney, Australia, School of Medical Sciences, University of New South Wales, Sydney, Australia

Peter R. Schofield

Affiliations Neuroscience Research Australia, Sydney, Australia, School of Medical Sciences, University of New South Wales, Sydney, Australia

Pau Pastor

Affiliations Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain, Department of Neurology, Clínica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain, CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain

John B. J. Kwok

j.kwok@neura.edu.au

Affiliations Neuroscience Research Australia, Sydney, Australia, School of Medical Sciences, University of New South Wales, Sydney, Australia

Competing Interests

Dr. Dobson-Stone and Dr. Kwok receive grant funding from the National Health and Medical Research Council of Australia (NHMRC). Dr. Panegyres provides services for Neurodegenerative Disorders Research Pty Ltd, a not-for-profit organization. Prof. Schofield receives grant funding from the NHMRC, Australian Research Council, National Institute of Health, Wicking Foundation and Beyond Blue Foundation. He has received speaker fees from Janssen-Cilag. He has held stock options (unexercised and now lapsed) in Brain Resource Ltd. He is Executive Director & CEO (paid employment) of Neuroscience Research Australia (a not-for-profit company) and Director (unpaid) of not-for-profit companies Neuroscience Research Australia Foundation, The Health-Science Alliance, and Neuroscience Australia (NSA). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: CDS PRS PP JBJK. Performed the experiments: CDS MH BS AEV. Analyzed the data: CDS WSB JBJK. Contributed reagents/materials/analysis tools: CTL EMT EH CMS PKP CR MSM RR JG JC WSB PP. Wrote the paper: CDS CTL WSB PRS PP JBJK.